US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist

60.080
+0.180+0.30%

Close Mar 19 16:00 ET

60.100
+0.020+0.03%

Pre 08:22 ET

121.92BMarket Cap-13.62P/E (TTM)

Bristol-Myers Squibb Stock Forum

Stock_Drift

Mar 11 16:58

$2seventy bio (TSVT.US)$ $Bristol-Myers Squibb (BMY.US)$

Teddy123

Mar 11 13:17

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

$2seventy bio (TSVT.US)$ $Bristol-Myers Squibb (BMY.US)$
Bristol Myers Squibb Snaps Up 2seventy bio at 88% Premium: Major Biotech Acquisition

Teddy123

Mar 8 22:57

Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis

$Bristol-Myers Squibb (BMY.US)$
First TYK2 Inhibitor Achieves 54% Success Rate in Major Arthritis Trial - A New Treatment Paradigm?

Reigno

Mar 7 23:45

$Bristol-Myers Squibb (BMY.US)$
Really glad I got those $63 calls when they were a $1 per contract

Reigno

Mar 1 03:09

$Bristol-Myers Squibb (BMY.US)$ Get in before next week🚀🚀

Peasant Investor

Feb 25 22:34

scaling out BMY & VOD

$BMY 250516 65.00C$
$VOD 250417 8.00C$

Unsupported feature. Please use the mobile app.

Teddy123

Feb 19 20:31

Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Surv

$Bristol-Myers Squibb (BMY.US)$
Landmark Cancer Treatment Victory: How Opdivo Just Changed Early Lung Cancer Survival Odds

Teddy123

Feb 17 13:28

New Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates in Moderate-to-Severe Plaque Psoriasis

$Bristol-Myers Squibb (BMY.US)$
Major Clinical Trial Results: Sotyktu Maintains 46% Complete Skin Clearance After 5 Years

Kevin Travers

Feb 7 05:34

Columns Wall Street Today: Earnings Results Pushing Climbing Market Higher

The market climbed Thursday as earnings results painted a steady picture of retail health for the fourth quarter of 2024. A gaggle of stocks on the S&P 500 hit 52-week highs.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.36%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.28%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.51%.
MACRO
Thursday macro showed 219k people filed for unemployment in the US l...

CPI jumps: Fed rate cuts unlikely?

Kevin Travers

Feb 6 23:47

Columns Live Stock News: RBLX Drops Like Rock, Drug Makers and Retailers Earn

Markets climbed after earnings calls came out from retailers and drug makers- one stock dropped 21%, and you'll never guess why.
Happy Thursday investors; it's February 6th, so let's check out the Live Stock News.
$Ralph Lauren (RL.US)$ climbed 15% at open after the company reported an 11% increase in quarterly revenue and raised its fiscal-year outlook. $Tapestry (TPR.US)$ soared 14% after the luxury fashion company reported ...